LUNG Pulmonx Corp
Nasdaq · SEC CIK 1127537 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $547.9K 16 sales by 5 insiders
- Filings on record
- 173 since 2021-07-13, latest 2026-09-03 18:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| French Glendon E. III | Pres, CEO, Dir | — | $292.3K |
| Lehman David Aaron | GC | — | $88.5K |
| Radhakrishnan Srikanth | Chief Science, Techn. Off | — | $69.5K |
| Rose Geoffrey Beran | Chief Commercial Off | — | $51.1K |
| Florin Daniel P | Dir | — | $46.4K |
| Sullivan Tiffany | Dir | — | — |
| Melenikiotou Georgia | Dir | — | — |
| Sung Derrick | COO, CFO | — | — |
| Burns Thomas William | Dir | — | — |
| Mead Dana G Jr. | Dir | — | — |
Transactions 199
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-25 | 2023-10-23 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $8.35 | -1,184 | 250.7K | -0.5% | -$9,886 | |
| 2023-09-26 | 2023-09-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $10.51 | -1,184 | 251.8K | -0.5% | -$12.4K | |
| M | 2023-09-06 | 2023-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $10.01 | -6,527 | 1.17M | -0.6% | -$65.3K |
| M | 2023-09-06 | 2023-09-01 | LUNG | Sung Derrick | CFO | S - Sale | $10.00 | -4,219 | 394.2K | -1% | -$42.2K |
| M | 2023-09-06 | 2023-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $10.01 | -2,843 | 253.0K | -1% | -$28.5K |
| M | 2023-09-06 | 2023-09-01 | LUNG | Lehman David Aaron | GC | S - Sale | $10.01 | -3,772 | 156.3K | -2% | -$37.8K |
| 2023-08-25 | 2023-08-23 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $10.54 | -1,184 | 255.9K | -0.5% | -$12.5K | |
| 2023-07-24 | 2023-07-20 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $12.68 | -15.0K | 1.17M | -1% | -$190.2K | |
| 2023-06-20 | 2023-06-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $12.68 | -10.0K | 1.19M | -0.8% | -$126.8K | |
| M | 2023-06-02 | 2023-06-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $11.48 | -2,845 | 259.5K | -1% | -$32.7K |
| 2023-06-02 | 2023-06-01 | LUNG | Mead Dana G Jr. | Dir | A - Grant | $0.00 | +12.6K | 47.3K | +36% | $0 | |
| M | 2023-06-02 | 2023-06-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $11.48 | -6,533 | 1.21M | -0.5% | -$75.0K |
| 2023-06-02 | 2023-06-01 | LUNG | Lynch Alissa Hsu | Dir | A - Grant | $0.00 | +12.6K | 24.5K | +106% | $0 | |
| M | 2023-06-02 | 2023-06-01 | LUNG | Lehman David Aaron | GC | S - Sale | $11.48 | -3,776 | 160.8K | -2% | -$43.3K |
| 2023-06-02 | 2023-06-01 | LUNG | Ferrari Richard | Dir | A - Grant | $0.00 | +12.6K | 42.7K | +42% | $0 | |
| 2023-06-02 | 2023-06-01 | LUNG | Burns Thomas William | Dir | A - Grant | $0.00 | +12.6K | 21.0K | +150% | $0 | |
| 2023-06-02 | 2023-06-01 | LUNG | Melenikiotou Georgia | Dir | A - Grant | $0.00 | +12.6K | 47.3K | +36% | $0 | |
| 2023-06-02 | 2023-06-01 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +12.6K | 22.8K | +124% | $0 | |
| M | 2023-06-02 | 2023-06-01 | LUNG | Sung Derrick | CFO | S - Sale | $11.49 | -4,222 | 398.4K | -1% | -$48.5K |
| 2023-06-02 | 2023-06-01 | LUNG | Florin Daniel P | Dir | A - Grant | $0.00 | +12.6K | 25.8K | +96% | $0 | |
| D | 2023-03-03 | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +173.5K | 1.21M | +17% | $0 |
| DM | 2023-03-03 | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $11.03 | -2,895 | 1.03M | -0.3% | -$31.9K |
| D | 2023-03-03 | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +78.9K | 259.9K | +44% | $0 |
| DM | 2023-03-03 | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $11.03 | -1,206 | 181.8K | -0.7% | -$13.3K |
| DM | 2023-03-03 | 2023-03-01 | LUNG | Lehman David Aaron | GC | S - Sale | $11.03 | -1,264 | 43.7K | -3% | -$13.9K |
| D | 2023-03-03 | 2023-03-01 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +118.3K | 161.2K | +276% | $0 |
| DM | 2023-03-03 | 2023-03-01 | LUNG | Sung Derrick | CFO | S - Sale | $11.03 | -1,264 | 261.5K | -0.5% | -$13.9K |
| D | 2023-03-03 | 2023-03-01 | LUNG | Sung Derrick | CFO | A - Grant | $0.00 | +138.0K | 399.5K | +53% | $0 |
| M | 2022-12-05 | 2022-12-01 | LUNG | Sung Derrick | CFO | S - Sale | $5.93 | -1,069 | 262.7K | -0.4% | -$6,339 |
| M | 2022-12-05 | 2022-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $5.93 | -3,631 | 1.04M | -0.3% | -$21.5K |
| M | 2022-12-05 | 2022-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $5.93 | -1,069 | 44.2K | -2% | -$6,339 |
| M | 2022-12-05 | 2022-12-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $5.93 | -1,055 | 181.0K | -0.6% | -$6,256 |
| 2022-12-01 | 2022-11-29 | LUNG | Lynch Alissa Hsu | Dir | P - Purchase | $5.51 | +1,700 | 11.9K | +17% | +$9,367 | |
| D | 2022-11-14 | 2022-11-14 | LUNG | French Glendon E. III | Pres, CEO, Dir | M - OptEx | $2.20 | +10.0K | 1.04M | +1.0% | +$22.0K |
| D | 2022-11-14 | 2022-11-14 | LUNG | Sung Derrick | CFO | M - OptEx | $2.20 | +10.0K | 263.8K | +4% | +$22.0K |
| M | 2022-11-10 | 2022-11-08 | LUNG | Ferrari Richard | Dir | P - Purchase | $5.31 | +5,438 | 29.9K | +22% | +$28.9K |
| 2022-09-19 | 2022-09-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $20.00 | -25.0K | 1.03M | -2% | -$500.0K | |
| M | 2022-09-06 | 2022-09-01 | LUNG | Sung Derrick | CFO | S - Sale | $17.87 | -1,082 | 254.5K | -0.4% | -$19.3K |
| M | 2022-09-06 | 2022-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $17.87 | -2,940 | 1.05M | -0.3% | -$52.5K |
| M | 2022-09-06 | 2022-09-01 | LUNG | Lehman David Aaron | GC | S - Sale | $17.88 | -1,082 | 45.2K | -2% | -$19.4K |
| M | 2022-09-06 | 2022-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $17.89 | -1,027 | 182.7K | -0.6% | -$18.4K |
| 2022-08-22 | 2022-08-18 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $20.59 | -50.0K | 1.06M | -5% | -$1.03M | |
| 2022-06-07 | 2022-06-01 | LUNG | Ferrari Richard | Dir | A - Grant | $0.00 | +5,600 | 24.6K | +29% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Lynch Alissa Hsu | Dir | A - Grant | $0.00 | +5,600 | 10.2K | +121% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Florin Daniel P | Dir | A - Grant | $0.00 | +5,600 | 13.1K | +74% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Burns Thomas William | Dir | A - Grant | $0.00 | +5,600 | 8,410 | +199% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Melenikiotou Georgia | Dir | A - Grant | $0.00 | +5,600 | 34.7K | +19% | $0 | |
| M | 2022-06-03 | 2022-06-01 | LUNG | Sung Derrick | CFO | S - Sale | $18.05 | -1,065 | 255.6K | -0.4% | -$19.2K |
| M | 2022-06-03 | 2022-06-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $18.05 | -2,523 | 1.10M | -0.2% | -$45.5K |
| M | 2022-06-03 | 2022-06-01 | LUNG | Lehman David Aaron | GC | S - Sale | $18.05 | -1,065 | 46.3K | -2% | -$19.2K |
| M | 2022-06-03 | 2022-06-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $18.05 | -1,011 | 183.1K | -0.5% | -$18.2K |
| 2022-06-03 | 2022-06-01 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +5,600 | 10.2K | +121% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Mead Dana G Jr. | Dir | A - Grant | $0.00 | +5,600 | 34.7K | +19% | $0 | |
| 2022-05-18 | 2022-05-16 | LUNG | French Glendon E. III | Pres, CEO, Dir | G - Gift | $0.00 | -25.0K | 1.11M | -2% | $0 | |
| D | 2022-03-11 | 2022-03-10 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | M - OptEx | $2.10 | +29.4K | 184.1K | +19% | +$61.8K |
| D | 2022-03-03 | 2022-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $25.91 | -1,132 | 1.06M | -0.1% | -$29.3K |
| D | 2022-03-03 | 2022-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +69.7K | 1.13M | +7% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | Sung Derrick | CFO | S - Sale | $25.91 | -458 | 225.0K | -0.2% | -$11.9K |
| D | 2022-03-03 | 2022-03-01 | LUNG | Sung Derrick | CFO | A - Grant | $0.00 | +31.0K | 256.0K | +14% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +31.0K | 154.7K | +25% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $25.91 | -426 | 123.7K | -0.3% | -$11.0K |
| D | 2022-03-03 | 2022-03-01 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +31.0K | 47.4K | +189% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | Lehman David Aaron | GC | S - Sale | $25.91 | -458 | 16.4K | -3% | -$11.9K |
| M | 2022-02-22 | 2022-02-17+ | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $27.07 | -25.0K | 1.07M | -2% | -$676.6K |
| M | 2022-01-24 | 2022-01-20+ | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $25.11 | -25.0K | 1.09M | -2% | -$627.7K |
| M | 2021-12-17 | 2021-12-16 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $31.05 | -25.0K | 1.12M | -2% | -$776.2K |
| M | 2021-12-16 | 2021-12-15 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $30.55 | -22.0K | 123.5K | -15% | -$672.0K |
| M | 2021-12-16 | 2021-12-14+ | LUNG | Sung Derrick | CFO | S - Sale | $31.71 | -6,000 | 228.4K | -3% | -$190.3K |
| DA | 2021-12-03 | 2021-04-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | M - OptEx | $2.20 | +25.0K | 1.27M | +2% | +$55.0K |
| DMA | 2021-12-03 | 2021-04-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale+OE | $43.75 | -25.0K | 1.25M | -2% | -$1.09M |
| 2021-12-03 | 2021-12-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $32.73 | -355 | 145.5K | -0.2% | -$11.6K | |
| 2021-12-03 | 2021-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $32.73 | -1,421 | 1.14M | -0.1% | -$46.5K | |
| 2021-12-03 | 2021-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $32.73 | -383 | 16.8K | -2% | -$12.5K | |
| DMA | 2021-12-03 | 2021-05-20 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale+OE | $41.95 | -25.0K | 1.25M | -2% | -$1.05M |
| DA | 2021-12-03 | 2021-05-20 | LUNG | French Glendon E. III | Pres, CEO, Dir | M - OptEx | $2.20 | +10.0K | 1.26M | +0.8% | +$22.0K |
| 2021-12-03 | 2021-12-01 | LUNG | Sung Derrick | CFO | S - Sale | $32.73 | -383 | 231.4K | -0.2% | -$12.5K | |
| M | 2021-11-22 | 2021-11-18 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $35.98 | -25.0K | 1.11M | -2% | -$899.5K |
| 2021-11-16 | 2021-11-15 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $39.94 | -7,000 | 145.8K | -5% | -$279.6K | |
| M | 2021-10-22 | 2021-10-21 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $39.75 | -25.0K | 1.13M | -2% | -$993.7K |
| 2021-10-18 | 2021-10-15 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $39.44 | -7,000 | 152.8K | -4% | -$276.1K | |
| M | 2021-09-21 | 2021-09-20+ | LUNG | Sung Derrick | CFO | S - Sale | $37.43 | -6,000 | 234.8K | -2% | -$224.6K |
| 2021-09-20 | 2021-09-16 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $38.86 | -25.0K | 1.16M | -2% | -$971.5K | |
| MI | 2021-09-20 | 2021-09-20 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $37.36 | -23.6K | 1,700 | -93% | -$880.6K |
| 2021-09-17 | 2021-09-15 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $38.12 | -7,000 | 159.8K | -4% | -$266.8K | |
| 2021-09-03 | 2021-09-01 | LUNG | Lynch Alissa Hsu | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 | |
| 2021-09-03 | 2021-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $40.09 | -355 | 166.8K | -0.2% | -$14.2K | |
| 2021-09-03 | 2021-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $40.09 | -1,421 | 1.18M | -0.1% | -$57.0K | |
| 2021-09-03 | 2021-09-01 | LUNG | Lehman David Aaron | GC | S - Sale | $40.09 | -383 | 17.2K | -2% | -$15.4K | |
| 2021-09-03 | 2021-09-01 | LUNG | Sung Derrick | CFO | S - Sale | $40.09 | -383 | 237.8K | -0.2% | -$15.4K | |
| 2021-09-03 | 2021-09-01 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 | |
| I | 2021-08-23 | 2021-08-19 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $36.59 | -1,000 | 23.6K | -4% | -$36.6K |
| 2021-08-23 | 2021-08-19 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $36.63 | -25.0K | 1.18M | -2% | -$915.8K | |
| 2021-08-18 | 2021-08-16 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $36.71 | -7,000 | 166.9K | -4% | -$257.0K | |
| D | 2021-07-19 | 2021-07-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | M - OptEx | $2.20 | +4,375 | 1.23M | +0.4% | +$9,625 |
| DM | 2021-07-19 | 2021-07-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale+OE | $38.73 | -25.0K | 1.21M | -2% | -$968.2K |
| DMI | 2021-07-19 | 2021-07-15 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale+OE | $38.70 | -1,000 | 25.4K | -4% | -$38.7K |
| M | 2021-07-19 | 2021-07-15 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $38.73 | -7,000 | 174.0K | -4% | -$271.1K |
| 2021-07-14 | 2021-07-13 | LUNG | BOSTON SCIENTIFIC CORP | 10% | S - Sale | $37.45 | -2.50M | 1.49M | -63% | -$93.62M | |
| 2021-07-13 | 2021-07-12 | LUNG | Florin Daniel P | Dir | P - Purchase | $40.00 | +2,500 | 7,532 | +50% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations